Brief: Suvretta Capital Management Llc Reports 9.3% Passive Stake In Contineum Therapeutics As Of April 5 - SEC Filing
April 15 (Reuters) - Contineum Therapeutics Inc
CTNM.O :
* SUVRETTA CAPITAL MANAGEMENT, LLC REPORTS 9.3% PASSIVE
STAKE IN
CONTINEUM THERAPEUTICS AS OF APRIL 5 - SEC FILING
Source text for Eikon: ID:n0000919574-24-002557
Further company coverage: CTNM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Contineum Therapeutics
See all newsPREVIEW: Johnson & Johnson earnings expected to decline in Q3
PREVIEW: Johnson & Johnson earnings expected to decline in Q3
US STOCKS ON THE MOVE-Microsoft, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers
Contineum tumbles as Bristol's partial trial win raises dose doubts